Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the S. 1229, the Supplemental Oxygen Access Reform (SOAR) Act.
Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry.
Issues related to H.R. 5555, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2023.
Issues related to S. 1294, the Competitive Bidding Relief Act of 2023.
Duration: December 1, 2014
to
present
General Issues: Health Issues , Budget/Appropriations , Government Issues , Defense
Spending: about $1,490,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: U.S. Senate, House of Representatives, White House Office, Office of Management & Budget (OMB)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Corry Marshall
CoS - Congressman Bob Gibbs; Senior LA - Congresswoman Melissa Hart; SA - House Transportation & Infrastructure Committee; SA - Congressman Bob Ney
COS - Congressman Bob Gibbs; Senior LA - Congresswoman Melissa Hart; SA - House Transportation & Infrastructure Committee; SA - Congressman Bob Ney
Erik Komendant
Legislative Correspondent, Rep. Zoe Lofgren (CA);
Legislative Director, Rep. Jason Altmire (PA);
Policy Director, Blue Dog Coalition
Thomas Worrall
n/a
Martin Whitmer
n/a
Robert Houton
n/a
Rudy Barry
n/a
Mariel Calhoun
n/a
Angela Acampora
n/a
Tom Worrall
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on April 19.
Original Filing: 301566761.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the S. 1229, the Supplemental Oxygen Access Reform (SOAR) Act.
Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry.
Issues related to H.R. 5555, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2023.
Issues related to S. 1294, the Competitive Bidding Relief Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 18.
Original Filing: 301528934.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the S. 1229, the Supplemental Oxygen Access Reform (SOAR) Act.
Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry.
Issues related to H.R. 5555, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2023.
Issues related to S. 1294, the Competitive Bidding Relief Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Oct. 3, 2023.
Original Filing: 301497292.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the S. 1229, the Supplemental Oxygen Access Reform (SOAR) Act.
Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry.
Issues related to H.R. 5555, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2023.
Issues related to S. 1294, the Competitive Bidding Relief Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $50,000. The report was filed on July 13, 2023.
Original Filing: 301475510.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the S. 1229, the Supplemental Oxygen Access Reform (SOAR) Act.
Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on April 18, 2023.
Original Filing: 301455642.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the S. 1229, the Supplemental Oxygen Access Reform (SOAR) Act.
Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 18, 2023.
Original Filing: 301430936.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Issues related to supply chain challenges for the healthcare industry.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $20,000. The report was filed on Oct. 17, 2022.
Original Filing: 301405553.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Issues related to supply chain challenges for the healthcare industry.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on July 14, 2022.
Original Filing: 301380363.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Issues related to supply chain challenges for the healthcare industry.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on April 18, 2022.
Original Filing: 301359190.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 19, 2022.
Original Filing: 301327509.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $20,000. The report was filed on Oct. 19, 2021.
Original Filing: 301304093.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 1319, the American Rescue Plan Act of 2021.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Issues related to H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $50,000. The report was filed on July 19, 2021.
Original Filing: 301281965.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 1319, the American Rescue Plan Act of 2021.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Issues related to H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $20,000. The report was filed on April 18, 2021.
Original Filing: 301255499.xml
Lobbying Issues
Issues related to the home healthcare equipment market. Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to H.R. 1319, the American Rescue Plan Act of 2021.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Issues related to H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233826.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act and adjustments to DME equipment.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $50,000. The report was filed on Oct. 15, 2020.
Original Filing: 301210972.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act and adjustments to DME equipment.
Issues related to H.R. 8158, To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $20,000. The report was filed on July 17, 2020.
Original Filing: 301192721.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act and adjustments to DME equipment.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on April 16, 2020.
Original Filing: 301168378.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Issues related to the implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act and adjustments to DME equipment.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108973.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Issues related to audits imposed on the home healthcare equipment industry.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Oct. 18, 2019.
Original Filing: 301070865.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on July 17, 2019.
Original Filing: 301047659.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on April 16, 2019.
Original Filing: 301026110.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of H.R. 24, the 21st Century Cures Act.
Issues related to competitive bidding reform.
Issues related to the Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 18, 2019.
Original Filing: 301007989.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of H.R. 24, the 21st Century Cures Act.
Issues related to competitive bidding reform.
Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Oct. 15, 2018.
Original Filing: 300985596.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of H.R. 24, the 21st Century Cures Act.
Issues related to competitive bidding reform.
Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $50,000. The report was filed on July 18, 2018.
Original Filing: 300967641.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of H.R. 24, the 21st Century Cures Act.
Issues related to competitive bidding reform.
Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on April 18, 2018.
Original Filing: 300947867.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of H.R. 24, the 21st Century Cures Act.
Issues related to competitive bidding reform.
Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Issues related to H.R. 4229, the Protecting Home Oxygen & Medical Equipment (HOME) Access Act of 2017.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Jan. 18, 2018.
Original Filing: 300927008.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of H.R. 24, the 21st Century Cures Act.
Issues related to competitive bidding reform.
Issues related to the pending Interim Final Regulation (IFR) entitled, "Durable Medical Equipment Fee Schedule, Adjustments to Resume the Transitional 50/50 Blended Rates to Provide Relief in Non-Competitive Bidding Areas."
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on Oct. 18, 2017.
Original Filing: 300906659.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of the 21st Century Cures Act HR 34.
Issues related to competitive bidding reform.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on July 17, 2017.
Original Filing: 300885524.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS and DME rulemaking.
Issues related to the implementation of the 21st Century Cures Act HR 34.
Issues related to competitive bidding reform.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
1st Quarter, 2017
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $40,000. The report was filed on April 18, 2017.
Original Filing: 300867400.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to the CMS Round 3 DME Rule.
Issues related to the Patient Access to Durable Medical Equipment (PADME) Act of 2016 HR 5210 and S 2736.
Issues related to the implementation of the 21st Century Cures Act HR 34.
Issues related to competitive bidding reform.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
4th Quarter, 2016
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on Jan. 19, 2017.
Original Filing: 300850471.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS Round 3 DME Rule.
Issues related to the Patient Access to Durable Medical Equipment (PADME) Act of 2016 HR 5210 and S 2736.
Issues related to the 21st Century Cures Act HR 34.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to the FY17 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on Oct. 17, 2016.
Original Filing: 300829409.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS Round 3 DME Rule.
Issues related to the Patient Access to Durable Medical Equipment (PADME) Act of 2016 HR 5210 and S 2736.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to the FY17 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on July 15, 2016.
Original Filing: 300810584.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS Round 3 DME Rule.
Issues related to the Patient Access to Durable Medical Equipment Act of 2016 HR 5210 and S 2736.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to the FY17 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $30,000. The report was filed on April 18, 2016.
Original Filing: 300793612.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS Round 3 DME Rule.
Issues related to the Patient Access to Durable Medical Equipment Act of 2016 S 2736.
Issues related to the Protecting Access through Competitive-pricing Transition (PACT) Act of 2015 HR 4185.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to FY17 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
WHITMER & WORRALL, LLC amended a lobbying report for representation of Rotech Healthcare Inc. in Q42015 on April 14, 2016.
Original Filing: 300791458.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS Round 3 DME Rule.
Issues related to the DME Access and Stabilization Act of 2015 S 2312.
Issues related to the Protecting Access through Competitive-pricing Transition (PACT) Act of 2015 HR 4185.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to small business activities and procurement contracting in the Veterans Affairs department.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 NDAA.
Issues related to procurement contracts.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $80,000. The report was filed on Jan. 15, 2016.
Original Filing: 300772427.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to CMS Round 3 DME Rule.
Issues related to the DME Access and Stabilization Act of 2015 S 2312.
Issues related to the Protecting Access through Competitive-pricing Transition (PACT) Act of 2015 HR 4185.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to small business activities and procurement contracting in the Veterans Affairs department.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 NDAA.
Issues related to procurement contracts.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $80,000. The report was filed on Oct. 18, 2015.
Original Filing: 300756070.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to the SGR: HR 2.
Issues related to CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to small business activities and procurement contracting in the Veterans Affairs department.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 NDAA.
Issues related to procurement contracts.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $70,000. The report was filed on July 15, 2015.
Original Filing: 300735376.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to the SGR: HR 2.
Issues related to CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to small business activities and procurement contracting in the Veterans Affairs department.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 LHHS Appropriations Bill.
Issues related to DME market and CMS Round 3 DME Rule.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FY16 NDAA.
Issues related to procurement contracts.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. , earning $50,000. The report was filed on April 17, 2015.
Original Filing: 300718642.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Issues related to the SGR: HR 2.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, WHITMER & WORRALL, LLC lobbied for Rotech Healthcare Inc. . The report was filed on Jan. 19, 2015.
Original Filing: 300700418.xml
Lobbying Issues
Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2014
Whitmer & Worrall, LLC filed a lobbying registration on Dec. 11, 2014 to represent Rotech Healthcare Inc., effective Dec. 1, 2014.
Original Filing: 300691877.xml
Issue(s) they said they’d lobby about: Issues related to the home healthcare equipment market.
Issues related to Medicare reimbursement levels. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate